Chimeric Antigen Receptor T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: A Canadian Perspective. Can Hematol Today 2022, 1 (2), 26–33. https://doi.org/10.58931/cht.2022.1214.